Baxter Supports Launch of ISMP International Fellowship Program
HORSHAM, Pa., & DEERFIELD, Ill.--(BUSINESS WIRE)--Mar. 15, 2017--
The Institute for Safe Medication Practices (ISMP), with the support of
Baxter International, is launching a two-year International Safe
Medication Management Fellowship program. The goal of the program is to
elevate awareness and to provide healthcare professionals with the
education, tools and training to advance medication error prevention in
the United States and around the world.
“We greatly appreciate Baxter’s support for the International Safe
Medication Management Fellowship program,” said Michael R. Cohen, RPh,
MS, ScD (hon.), DPS (hon.), FASHP, president, ISMP. “Preventing
medication errors is an issue of global importance and this program will
help advance prevention strategies—including the use of prefilled
syringes, premixed medications and new systems of error reporting—that
can be implemented in healthcare settings around the world.”
Unsafe medication practices and medication errors are a cause of
significant patient harm and injury globally. World Health Organization
data from European Union Member States consistently shows that medical
errors and healthcare-related adverse events occur in 8-12 percent of
hospitalizations. And 11 percent of European Union citizens claim to
have been prescribed the wrong medication1. In the United
States, the U.S. Food and Drug Administration (FDA) reports medication
errors cause at least one death every day and injure approximately 1.3
million people annually2.
“Medication errors can occur at any point in the healthcare delivery
system, which is why Baxter puts such a high priority on helping prevent
errors from ever reaching patients,” said Dheerendra Kommala, M.D., vice
president, Medical Affairs, Baxter. “The ISMP Fellowship programs allow
healthcare practitioners to identify best practices in medication error
prevention and equip them with the tools and training for implementation
in their local markets to advance patient safety.”
As part of the International Safe Medication Management Fellowship
program, which will be based at ISMP’s offices in Horsham, Pennsylvania,
participants will work directly with domestic and international
professional medication safety organizations, such as the International
Medication Safety Network (IMSN). Fellows will attend critical
multi-country medication safety events and collaborate on efforts to
address unsafe naming, labeling and packaging of medicines. They will
advocate for standardized safe medication practices that can improve
global medication safety. And they will advance medication management
safety strategies and global reporting of medication errors to drive
awareness of unsafe medication practices.
The announcement of the new international fellowship comes as ISMP and
Baxter recognize Patient Safety Awareness Week, taking place March 12 –
18, 2017. Patient Safety Awareness Week is an effort to increase
awareness of patient safety issues among health professionals and the
public across the United States.
For more information on ISMP’s fellowship programs or to apply, visit: http://www.ismp.org/profdevelopment/managementfellowship.asp.
The Institute for Safe Medication Practices (ISMP) is an independent,
nonprofit charitable organization that works closely with healthcare
practitioners and institutions, regulatory agencies, consumers, and
professional organizations to provide education about medication errors
and their prevention. ISMP represents more than 40 years of experience
in helping healthcare practitioners keep patients safe, and continues to
lead efforts to improve the medication use process. For more information
on ISMP, or its medication safety alert newsletters and other tools for
healthcare professionals and consumers, visit www.ismp.org.
Baxter International Inc. provides a broad portfolio of essential renal
and hospital products, including home, acute and in-center dialysis;
sterile IV solutions; infusion systems and devices; parenteral
nutrition; biosurgery products and anesthetics; and pharmacy automation,
software and services. The company’s global footprint and the critical
nature of its products and services play a key role in expanding access
to healthcare in emerging and developed countries. Baxter’s employees
worldwide are building upon the company’s rich heritage of medical
breakthroughs to advance the next generation of healthcare innovations
that enable patient care.
1 "Data and Statistics." WHO/Europe. World
Health Organization, 01 Mar. 2017. Web. 01 Mar. 2017.
Center for Drug Evaluation and Research. "Medication Errors - Medication
Error Reports." U S Food and Drug Administration Home Page.
Center for Drug Evaluation and Research, 20 Oct. 2016. Web. 01 Mar. 2017.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170315005048/en/
Source: Baxter International Inc.
Renee Brehio, (614) 376-0212
Jori Fine, (224) 948-5353